Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Steve Fancy who wrote (4326)	5/18/1998 7:17:00 PM
From: Marc Bourgault	Read Replies (2) \| Respond to of 6136

Stop hitting Mrs Wang, I admire her constancy. Even if I bought the stock based on her recommendation a couple of years and it is down a little, I believe in the end she will be vindicated. For instance, a couple of minutes ago, I watched a piece on ABC World News, in which the reporter (I believe it was George Strait covering the LA conference), talked at length about angiogenesis and the remarkable results doctors were obtaining with a drug called VEGF. I believe AGPH is involved in that kind of research (see post no 4322), though ABC was very careful not to mention a company.